Mary F Mulcahy Selected Research

Yttrium-90

8/2022	Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
12/2021	Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
1/2019	TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
10/2018	Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
12/2016	Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
10/2014	Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
7/2014	Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.
4/2014	Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.
8/2013	Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
10/2012	Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary F Mulcahy Research Topics

Disease

67	Neoplasms (Cancer) 08/2022 - 01/2005
27	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 09/2005
17	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2005
14	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2002
8	Colonic Neoplasms (Colon Cancer) 01/2021 - 06/2002
8	Adenocarcinoma 01/2020 - 10/2011
8	Pancreatic Neoplasms (Pancreatic Cancer) 08/2014 - 09/2005
6	Fatigue 01/2022 - 01/2010
6	Rectal Neoplasms (Rectal Cancer) 01/2020 - 12/2004
5	Nausea 01/2022 - 01/2010
5	Necrosis 12/2016 - 03/2007
4	Cholangiocarcinoma 08/2022 - 10/2008
4	Hypoxia (Hypoxemia) 08/2011 - 11/2005
4	Fibrosis (Cirrhosis) 08/2011 - 09/2005
3	Microsatellite Instability 01/2022 - 01/2008
3	Disease Progression 01/2019 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 05/2011
3	Weight Loss (Weight Reduction) 01/2013 - 02/2006
3	Abdominal Pain (Pain, Abdominal) 07/2012 - 02/2011
2	Neutropenia 01/2020 - 01/2005
2	Pathologic Complete Response 01/2020 - 11/2012
2	Diarrhea 01/2020 - 07/2012
2	Carcinoma (Carcinomatosis) 03/2017 - 04/2012
2	Liver Neoplasms (Liver Cancer) 07/2014 - 05/2008
2	Pain (Aches) 04/2014 - 01/2010
2	Pneumonia (Pneumonitis) 12/2013 - 10/2011
2	Vomiting 07/2012 - 01/2010
2	Liver Diseases (Liver Disease) 07/2012 - 07/2005
2	End Stage Liver Disease 12/2006 - 09/2005
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Liposarcoma 01/2022
1	Wounds and Injuries (Trauma) 12/2020
1	Leukopenia 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Obesity 01/2020
1	Esophageal Squamous Cell Carcinoma 05/2018
1	Esophageal Neoplasms (Esophageal Cancer) 05/2018
1	Squamous Cell Carcinoma of Head and Neck 03/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

30	Yttrium-90IBA 08/2022 - 09/2005
9	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 06/2002
9	Bevacizumab (Avastin)FDA Link 01/2020 - 07/2005
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 07/2005
7	Leucovorin (Folinic Acid)FDA Link 01/2020 - 06/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
6	Gemcitabine FDA Link 08/2014 - 02/2006
5	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2005
5	YttriumIBA 08/2013 - 09/2005
5	BilirubinIBA 07/2012 - 01/2008
4	AlbuminsIBA 10/2014 - 01/2010
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2012 - 12/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2002
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2005
3	Monoclonal AntibodiesIBA 05/2007 - 07/2005
2	Cetuximab (Erbitux)FDA Link 01/2020 - 03/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2008
2	Thymidylate SynthaseIBA 01/2018 - 01/2008
2	Capecitabine (Xeloda)FDA Link 01/2017 - 04/2014
2	Pharmaceutical PreparationsIBA 09/2016 - 05/2012
2	thiamine triphosphorate (TTP)IBA 09/2016 - 06/2010
2	Trastuzumab (Herceptin)FDA Link 02/2015 - 05/2013
2	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 10/2008 - 05/2007
2	Polyvinyl AlcoholIBA 05/2007 - 11/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2007 - 07/2005
1	Serum AlbuminIBA 08/2022
1	selinexorIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 12/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2019
1	taxaneIBA 01/2019
1	Drug CombinationsIBA 01/2019
1	EnzymesIBA 05/2018
1	Messenger RNA (mRNA)IBA 05/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2018
1	VemurafenibIBA 04/2018
1	veliparibIBA 01/2017
1	RamucirumabIBA 02/2015

Therapy/Procedure

59	Therapeutics 01/2022 - 06/2002
24	Drug Therapy (Chemotherapy) 08/2022 - 06/2002
19	Microspheres (Microsphere) 01/2019 - 09/2005
14	Radiotherapy 03/2017 - 09/2005
5	Neoadjuvant Therapy 01/2020 - 10/2011
4	Aftercare (After-Treatment) 10/2013 - 03/2007
4	Radiofrequency Ablation 09/2009 - 09/2005
3	Chemoradiotherapy 01/2020 - 10/2011
3	Transplantation 08/2014 - 12/2006
2	Adjuvant Chemotherapy 12/2013 - 06/2002
2	Injections 10/2013 - 07/2006
2	Liver Transplantation 12/2006 - 09/2005
1	Length of Stay 12/2020
1	Infusion Pumps (Infusion Pump) 12/2020
1	Operative Time 12/2020
1	Secondary Prevention 01/2020
1	Colostomy 01/2020
1	Intravenous Infusions 01/2019